| scholarly article | Q13442814 |
| P50 | author | Lorenz Meinel | Q37829415 |
| Gordana Vunjak-Novakovic | Q54394 | ||
| Vassilis Karageorgiou | Q42037663 | ||
| David L. Kaplan | Q61761312 | ||
| Robert Fajardo | Q125226797 | ||
| P2093 | author name string | Jake Chen | |
| Brian Snyder | |||
| Katherine Wade | |||
| Michael Tomkins | |||
| P2860 | cites work | Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins | Q41963921 |
| P433 | issue | 2 | |
| P921 | main subject | morphogenesis | Q815547 |
| P304 | page(s) | 324-334 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Journal of Biomedical Materials Research Part A | Q15749234 |
| P1476 | title | Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo | |
| P478 | volume | 78 |
| Q57169514 | A Review on Properties of Natural and Synthetic Based Electrospun Fibrous Materials for Bone Tissue Engineering |
| Q38207599 | Adipose mesenchymal stem cells in the field of bone tissue engineering |
| Q37623498 | Application of bone growth factors--the potential of different carrier systems |
| Q37226424 | BMP-silk composite matrices heal critically sized femoral defects |
| Q42004336 | Bioactivity of porous biphasic calcium phosphate enhanced by recombinant human bone morphogenetic protein 2/silk fibroin microsphere |
| Q36326923 | Biomaterial-mediated strategies targeting vascularization for bone repair |
| Q55033975 | Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration. |
| Q37464368 | Biomedical applications of chemically-modified silk fibroin |
| Q36502929 | Biomimetic materials for tissue engineering |
| Q36827833 | Biomolecule gradient in micropatterned nanofibrous scaffold for spatiotemporal release |
| Q40993075 | Bone Regeneration Using Bone Morphogenetic Proteins and Various Biomaterial Carriers |
| Q24301292 | Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2) |
| Q37126334 | Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). |
| Q33999454 | Bone tissue engineering with human stem cells |
| Q33863343 | Characterization of dielectrophoresis-aligned nanofibrous silk fibroin-chitosan scaffold and its interactions with endothelial cells for tissue engineering applications |
| Q33746646 | Decellularized silk fibroin scaffold primed with adipose mesenchymal stromal cells improves wound healing in diabetic mice |
| Q36116157 | Degradation mechanism and control of silk fibroin |
| Q39652024 | Development of an in vitro model to study the impact of BMP-2 on metastasis to bone |
| Q41994101 | Development of silk-based scaffolds for tissue engineering of bone from human adipose-derived stem cells. |
| Q53361249 | Effects of flow configuration on bone tissue engineering using human mesenchymal stem cells in 3D chitosan composite scaffolds. |
| Q57218703 | Electrospun PLGA-silk fibroin-collagen nanofibrous scaffolds for nerve tissue engineering |
| Q35120178 | Electrospun silk fibroin nanofibers promote Schwann cell adhesion, growth and proliferation |
| Q28391832 | Engineering custom-designed osteochondral tissue grafts |
| Q35928301 | Epigenetically Modified Bone Marrow Stromal Cells in Silk Scaffolds Promote Craniofacial Bone Repair and Wound Healing. |
| Q42018010 | Evaluation of an injectable silk fibroin enhanced calcium phosphate cement loaded with human recombinant bone morphogenetic protein-2 in ovine lumbar interbody fusion |
| Q39143903 | Evaluation of phytochemical-incorporated porous polymeric sponges for bone tissue engineering: a novel perspective |
| Q42027989 | Evaluation on in vitro biocompatibility of silk fibroin-based biomaterials with primarily cultured hippocampal neurons |
| Q42920076 | Fabricating a pearl/PLGA composite scaffold by the low-temperature deposition manufacturing technique for bone tissue engineering |
| Q33639409 | Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration. |
| Q37995448 | Growth factor delivery: how surface interactions modulate release in vitro and in vivo |
| Q30488316 | Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering |
| Q51832744 | Heparin-induced conformational changes of fibronectin within the extracellular matrix promote hMSC osteogenic differentiation. |
| Q42020826 | In vitro and in vivo release of basic fibroblast growth factor using a silk fibroin scaffold as delivery carrier |
| Q37233876 | In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth |
| Q34781676 | In vivo degradation of three-dimensional silk fibroin scaffolds |
| Q51354929 | Increased Osteoid Formation in BMP-2-Loaded Silk-Based Screws. |
| Q33649702 | Is macroporosity absolutely required for preliminary in vitro bone biomaterial study? A comparison between porous materials and flat materials |
| Q34669298 | Mechanisms of controlled release from silk fibroin films |
| Q35516528 | Natural and Genetically Engineered Proteins for Tissue Engineering |
| Q40206948 | Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue |
| Q42026203 | Optimization strategies for electrospun silk fibroin tissue engineering scaffolds |
| Q34576810 | Osteoblastic differentiation and stress response of human mesenchymal stem cells exposed to alternating current electric fields |
| Q34715296 | Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold |
| Q33701343 | Osterix enhances BMSC-associated osseointegration of implants |
| Q42119713 | Patterned silk film scaffolds for aligned lamellar bone tissue engineering |
| Q35210906 | Porous silk scaffolds for delivery of growth factors and stem cells to enhance bone regeneration |
| Q47296936 | Prolonged delivery of BMP-2 by a non-polymer hydrogel for bone defect regeneration. |
| Q37978191 | Review physical and chemical aspects of stabilization of compounds in silk |
| Q42548787 | Scaffold structure and fabrication method affect proinflammatory milieu in three-dimensional-cultured chondrocytes. |
| Q34988084 | Silk as a Biomaterial |
| Q36151307 | Silk fibroin electrogelation mechanisms |
| Q43199560 | Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release |
| Q43172130 | Silk fibroin/chitosan-hyaluronic acid versus silk fibroin scaffolds for tissue engineering: promoting cell proliferations in vitro |
| Q38007146 | Silk materials--a road to sustainable high technology |
| Q39417535 | Silk nanospheres and microspheres from silk/pva blend films for drug delivery |
| Q37074986 | Silk-Its Mysteries, How It Is Made, and How It Is Used |
| Q38218638 | Silk-based biomaterials for sustained drug delivery |
| Q37714025 | Silk-based delivery systems of bioactive molecules. |
| Q47385691 | Simulation of ECM with Silk and Chitosan Nanocomposite Materials |
| Q57214834 | Simultaneous structuring and mineralization of silk fibroin scaffolds |
| Q37512645 | Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine |
| Q36106613 | Studies of bone morphogenetic protein-based surgical repair |
| Q87986537 | The Significance and Utilisation of Biomimetic and Bioinspired Strategies in the Field of Biomedical Material Engineering: The Case of Calcium Phosphat—Protein Template Constructs |
| Q42286000 | The effect of erythropoietin on autologous stem cell-mediated bone regeneration |
| Q53468151 | The efficacy of bone morphogenetic protein-2 depends on its mode of delivery. |
| Q42137407 | The influence of scaffold material on chondrocytes under inflammatory conditions |
| Q30770091 | The use of silk-based devices for fracture fixation |
| Q35200116 | Tissue engineering a surrogate niche for metastatic cancer cells |
| Q38924988 | Use of Pig as a Model for Mesenchymal Stem Cell Therapies for Bone Regeneration. |
| Q33695565 | Water-insoluble silk films with silk I structure |
Search more.